ImmunityBio, Inc. IBRX
At closeNov 13, 2026, 7:50 PM EST
After hours · Nov 13, 7:50 PM ET
- YTD
- +204.04%
- 1 year
- +201.00%
Discussion (3525)
Sign in to join the discussion
I logged on to Facebook Censorbook posted news and several links none of it stayed up all went to my page only!
Censorbook still censoring information!
Suspended my account again!
Post the story about ImmunityBio Anktiva on Facebook X everywhere! I don't use Facebook "Cencorbook" I was censored during Covid false and misleading even kicked off for posting the truth!
The stock will run higher every quarter going forward because of what? Rapidly increasing sales! A dramatic parabolic move only happens if more of the public knows about Anktiva and ImmunityBio. Don't be naive we need thousands of buyers chasing it to get the short squeeze many of you fantasize about.
Dr. Martin Makary he is an oncology surgeon pancreatic cancer was his specialty. Who else do we know that was his special interest of surgery! Oh Dr.PSS so he knows Anktiva's potential!
He is a physician surgeon first and not a Big Pharma puppet!
I just sent emails again
They all have email addresses to send News tips to!
NBC
Abc
CBS
60 minutes
CNBC
Foxb
Investor's Business Daily
Investor's Business Daily lol
Investor's business daily lol
Maybe my numerous emails to CNBC and FoxB New York Times Washington Post Innvertor business daily are working even if they don't run a story the info is being shared in house!
WRITE TO THE MSM and wake them up!
It's all about the pipeline
Bladder cancer
Glioblastoma
Lymphoma
Lynch Syndrome
Ovarian Cancer
Lung cancer
AIDS cure eliminate the virus
HPV eliminate from the host
Lymphopenia reversal
Don't forget about NK cell therapy infusions
Anktiva will be used alone or in combination for all cancer therapies. Merck's Keytruda will be obsolete and Anktiva will have sales over $50 billion a year in the near future!!!
Senior VIP
That's what needs to happen, spread the news! Call write MSM CNBC Foxb call them out for suppressing the ImmunityBio news to protect their ad revenues from Big Pharma
